[1]
Simpson, E.L. , Silverberg, J., Nosbaum, A., Winthrop, K., Guttman-Yassky, E., Hoffmeister, K.M., Egeberg, A., Valdez, H., Fan, H., Farooqui, S.A., Chan, G.L., Alderfer, J., Romero, W. and Johnson, S. 2023. Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s150. DOI:https://doi.org/10.25251/skin.7.supp.150.